Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
Sponsor: Chinese PLA General Hospital
Summary
A Dual-Center, Randomized, Controlled, Blinded, Prospective Study on the Effects of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery
Official title: Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
218
Start Date
2026-01-17
Completion Date
2027-02-01
Last Updated
2026-01-27
Healthy Volunteers
No
Conditions
Interventions
Esketamine 0.3mg/kg
A single dose of 0.3 mg/kg esketamine is administered intravenously during anesthesia induction, with the infusion completed over 40 minutes.
Normal Saline
Receiving the same volume of normal saline during induction of anesthesia during the same time
Locations (1)
First Medical center of Chinese PLA General Hospital
Beijing, China